CIRILLO, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 2.390
AS - Asia 1.683
EU - Europa 1.257
SA - Sud America 399
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 94
OC - Oceania 5
Totale 5.930
Nazione #
US - Stati Uniti d'America 2.303
SG - Singapore 634
IT - Italia 405
CN - Cina 319
BR - Brasile 273
VN - Vietnam 270
UA - Ucraina 185
DE - Germania 183
AT - Austria 127
BD - Bangladesh 122
FI - Finlandia 82
SE - Svezia 65
HK - Hong Kong 61
FR - Francia 58
IN - India 56
AR - Argentina 43
CA - Canada 43
SN - Senegal 41
GB - Regno Unito 40
KR - Corea 38
TR - Turchia 30
ID - Indonesia 26
NL - Olanda 26
ZA - Sudafrica 25
MX - Messico 24
CO - Colombia 20
IQ - Iraq 20
CZ - Repubblica Ceca 17
EC - Ecuador 16
PK - Pakistan 16
PL - Polonia 14
PY - Paraguay 14
BE - Belgio 13
VE - Venezuela 12
PH - Filippine 11
JP - Giappone 10
RU - Federazione Russa 9
CL - Cile 8
MA - Marocco 8
MY - Malesia 8
AZ - Azerbaigian 7
CR - Costa Rica 7
KZ - Kazakistan 7
PE - Perù 7
SA - Arabia Saudita 7
DZ - Algeria 6
ES - Italia 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
EG - Egitto 5
ET - Etiopia 5
KE - Kenya 5
UZ - Uzbekistan 5
AU - Australia 4
BO - Bolivia 4
IE - Irlanda 4
IL - Israele 4
JM - Giamaica 4
JO - Giordania 4
BY - Bielorussia 3
HU - Ungheria 3
OM - Oman 3
RS - Serbia 3
AL - Albania 2
AO - Angola 2
LB - Libano 2
LK - Sri Lanka 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.836
Città #
Dallas 366
Singapore 263
Chandler 256
San Jose 223
Ashburn 157
New York 125
Beijing 102
Vienna 94
Council Bluffs 93
Boardman 88
Jacksonville 88
Ho Chi Minh City 85
Hanoi 74
San Mateo 72
Helsinki 58
Hong Kong 58
Dearborn 57
Munich 49
Rende 44
Dakar 41
Seoul 38
Los Angeles 35
Shanghai 34
Lauterbourg 32
Milan 32
São Paulo 31
Florence 29
Lawrence 28
Hefei 26
Roxbury 26
Brooklyn 25
Santa Clara 23
Bremen 19
Seattle 19
Rome 18
Izmir 17
Ann Arbor 16
Brno 15
Haiphong 15
Des Moines 14
The Dalles 14
Brussels 13
Johannesburg 13
San Francisco 13
Turku 13
Biên Hòa 12
Chennai 12
Columbus 12
Frankfurt am Main 12
Naples 12
Orem 12
Wilmington 12
Bari 11
Ottawa 11
Warsaw 11
Montreal 10
Pune 10
Stockholm 10
Amantea 9
Cosenza 9
Messina 9
Ogden 9
Amsterdam 8
Brasília 8
Buenos Aires 8
Guayaquil 8
Mexico City 8
Rio de Janeiro 8
Tokyo 8
Toronto 8
Baghdad 7
Baku 7
Catanzaro 7
Chicago 7
Da Nang 7
Dhaka 7
Espoo 7
Guangzhou 7
Inglewood 7
Jakarta 7
London 7
Omaha 7
Redmond 7
Redwood City 7
Buffalo 6
San José 6
Tampa 6
Tianjin 6
Turin 6
Ankara 5
Asunción 5
Caracas 5
Falkenstein 5
Huế 5
Kuala Lumpur 5
Lima 5
Medellín 5
Mumbai 5
Tashkent 5
Thái Nguyên 5
Totale 3.381
Nome #
Computational Approaches for the Discovery of GPER Targeting Compounds 275
AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs) 239
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells 236
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells 220
GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells Toward Breast Tumor Progression 212
Estrogenic GPER signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (CAFs) 211
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 189
Apoptosis of breast cancer cells induced by lauric acid occours through p21Cip/WAF1 in a p53 independent manner 188
miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) 188
Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression 182
The lauric acid-activated signaling prompts apoptosis in cancer cells 177
Interleukin-1β mediates a tumor-supporting environment prompted by IGF1 in triple-negative breast cancer (TNBC) 176
Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer (TNBC) 170
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 167
Protective role of GPER Agonist G-1 on cardiotoxicity induced by doxorubicin 162
The Ephrin tyrosine kinase a3 (EphA3) is a novel mediator of RAGE-prompted motility of breast cancer cells 158
Identification of novel estrogen-regulated microRNAs in breast tumor cells and cancer-associated fibroblasts (CAFS) 155
Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts 155
Estrogenic Gper-signaling triggers RERG expression in breast cancer cells and cancer-associated fibroblasts 154
IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells 153
A Review on the Antimicrobial Activity of Schiff Bases: Data Collection and Recent Studies 147
Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients 144
The IL1β-IL1R signaling is involved in the stimulatory effects triggered by hypoxia in breast cancer cells and cancer-associated fibroblasts (CAFs) 144
GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer 141
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 140
GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway 139
Newly Synthesized Imino-Derivatives Analogues of Resveratrol Exert Inhibitory Effects in Breast Tumor Cells 135
GPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response 133
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells 128
Novel Aspects Concerning the Functional Cross-Talk between the Insulin/IGF-I System and Estrogen Signaling in Cancer Cells 127
miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling 126
Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells 119
Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells 112
RAGE inhibition blunts insulin-induced oncogenic signals in breast cancer 105
IGF-I/IGF-IR Transduction System Involves GPER and DDR1 in the Stimulation of Mesothelioma and Lung Cancer Cells 104
Harnessing sample preparation for RNA-sequencing toward a reliable bioinformatics analysis 96
Triple-negative breast cancer drug resistance, durable efficacy, and cure: How advanced biological insights and emerging drug modalities could transform progress 69
Environmental plastic pollutants and endocrine-related cancer: An updated view 35
Alternate actions of CDK4/6 inhibitors beyond cell cycle blockade: unexplored roles in therapy resistance 19
Totale 5.930
Categoria #
all - tutte 29.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.528


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022381 0 57 1 25 43 12 8 87 7 1 51 89
2022/2023656 81 91 30 105 71 53 2 71 70 15 47 20
2023/2024508 76 28 30 20 22 113 23 50 28 17 17 84
2024/2025887 44 85 34 76 35 58 67 66 131 54 85 152
2025/20262.701 249 113 481 146 376 219 300 155 199 162 152 149
2026/2027243 175 68 0 0 0 0 0 0 0 0 0 0
Totale 5.930